June 2005

E-Media

January 2, 2008

New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific Discovery Solutions, which enable drug researchers to improve their productivity and maximize their investments in […]

On the Calendar

January 2, 2008

June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah Lieberman at 877-339-4479, e-mail mlieberman@pharmavoice.com, or visit knowledgeshareforums.com. June 6-7 Early Stage Risk Management: Bridging Toxicology […]

Talent Pool

January 2, 2008

Pharma POOL Jean-Louis Anspach Michael R. Dornhecker Ann Willmoth Solvay Pharmaceuticals Announces Key Promotions Solvay Pharmaceuticals, Marietta, Ga., has named Jean-Louis Anspach as VP, commercial operations, responsible for managing all aspects of the primary-care business unit, including sales and marketing activities for its specialized markets and cardiology portfolios. Solvay Pharmaceuticals is a research-driven pharmaceutical company […]

Ideology Vs. Science: The Stem-Cell Battle

January 2, 2008

Ideology Vs. Science: The Stem-Cell Battle By Kim Ribbink Across the globe, scientists are extolling the potential of stem- cell research to cure debilitating diseases, in spite of limits on federal funding as well as controversy surrounding the research. States and private investors have begun to step into the fray, and experts argue the importance […]

Translational Research: Making the Transition from R to D

January 2, 2008

Translational Research: Making the Transition from R to D There is a growing interest in translational research, which aims to bridge the gap between advances in basic research and the development of safe and effective therapies. June 2005 PharmaVOICE Despite increased investment in research and development and new technologies that have created novel targets, fewer […]

For Art’s Sake

January 2, 2008

Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Creating good pharmaceutical advertising and marketing requires agencies to think out of the box […]

DTC: The Next Phase

January 2, 2008

In light of FDA guidances, more public scrutiny, and trending corporate citizenship, DTC advertising is subtly shifting to direct-to-education. Direct-to-consumer advertising has been mainly focused on creating brand awareness for major blockbuster products, or creating awareness for new therapeutic categories, or both. Since 1997, when the FDA relaxed regulations on how drug companies can advertise […]

PharmaTrax

January 2, 2008

CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical schools or medical societies. This is the finding of a recent survey of 2,000 U.S. physicians conducted by […]

Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct

January 2, 2008

Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct What is risk? Why does it matter? Shouldn’t prudent business people try to avoid it? How does it impact the conduct of clinical trials, and can it or should it change? Timothy Pratt, Ph.D., Chief marketing officer of MedNet Solutions Inc., Minnetonka, Minn., a provider of […]

PharmaOutlet

January 2, 2008

Contributed by Jim Montgomery Building Effective Communications For the Life-Sciences Marketplace Open the latest issue of Science or Biotechniques, and browse through the ads. But be forewarned; it’s not pretty. First, there are the companies that clearly aspire to be marketers, all of them struggling to outdo the others in “cutting through the clutter.” Some […]

Table of Contents

January 2, 2008

on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this area, and companies are rethinking their policies on clinical-trial registries. FEATURES Translational […]

What’s New

January 2, 2008

New Healthcare-related Products, Services, and Companies PMI Appoints Task Force to Oversee CME Compliance Pri-Med Institute (PMI) has named a task force of medical and educational experts to ensure that all of its continuing medical education (CME) programs meet and exceed the new Standards of Commercial Support established by the Accreditation Council for Continuing Medical […]

David King — Regal Legal

January 2, 2008

Regal Legal By Kim Ribbink June 2005 PharmaVOICE From biotech’s early days in the mid-1980s, David R. King has played a central role in the industry, gaining a deep appreciation for science, the broad range of phases of business development, and what it takes to succeed. Years of experience representing the life-sciences industry during his […]

The Time for Transparency

January 2, 2008

June 2005 PharmaVOICE Trial transparency The Time for Transparency by Elisabeth Pena Villarroel The movement toward clinical-trial transparency and public registries is not a new idea, however, the highly publicized lawsuit by Eliot Spitzer against GlaxoSmithKline and the terms of the settlement set off a wave of activity by industry stakeholders about the transparency of […]

What’s on Your Mind — Opinions

January 2, 2008

What’s on Your Mind — Opinions Opinions Blogs, which often combine a mixture of what is happening in a person’s life and what is happening on the Web into a type of hybrid diary/guide site, are quickly becoming important online resources for consumers and patients. Bloggers share personal information with others about their willingness to […]

Letter from the Editor

January 2, 2008

PharmaVOICE June 2005 Letter from the Editor In 1990, some very smart women realized that to effect change in the industry, HBA was going to have to take an active role in recognizing women in leadership positions and increasing their visibility in the industry. “Since then, we have been recognizing women for their outstanding achievements, […]

FEEDBACK